How we score →

Dermatica (US) Review

✓ Updated July 2026 By the TelehealthIndex Editorial Team · How we score Fair · #7 in Hair Loss & Dermatology No affiliate relationship
Advertising Disclosure: TelehealthIndex is reader-supported. If you sign up with a provider through links on this page, we may earn a commission at no extra cost to you. Commissions never influence our scores or rankings — several of our top-rated providers pay us nothing. How we score → · Full disclosure →

Dermatica score

Fair · #7 in Hair Loss & Dermatology · Data as of July 2026 · No affiliate relationship
Clinical credibilityWeak
Regulatory & safety recordNotable deductions
Transparency & trustLimited
Access & coverageLimited
Customer experienceStrong
Value & pricingGood
Pillar ratings are qualitative summaries of our internal rubric; we do not publish the point weights. Read the full methodology →

TelehealthIndex scores and rankings are editorial opinions resulting from our selection, weighting, and interpretation of the factors described in our methodology.

What it is

Personalized compounded Rx skincare at the category's lowest price point; strong UK track record; smaller US footprint.

Strengths

  • Available in 40 states
  • Lower-cost pricing for the category
  • Strong consumer-review signals

Considerations

  • US state list incomplete (~10 excluded at launch - verify current)
  • US affiliate commissionability unverified (UK Awin programme)
Note: this provider offers compounded medications for one or more services. Compounded medications are not FDA-approved.
Founded2018
OwnershipHeliosX Group (UK)
Availability40 states
InsuranceNo
Money-back guaranteeNot advertised
Pricing$4.99 prescribing fee; $22.42-29.95/bottle (56-day supply)
Visit Dermatica We may earn a commission — disclosure.

Alternatives to consider

Musely Fair · #6 in Hair Loss & Dermatology — read review → Hims Not Recommended · #8 in Hair Loss & Dermatology — read review →

Data as of July 19, 2026. Scores are editorial opinions reflecting documented business practices, transparency, pricing, access, and nonclinical consumer-service factors — not clinical quality or outcomes. Found an error? Report it →